Endothelin Receptors
-
Zibotentan (ZD4054)
Catalog No. A11006 ETA-receptor 拮抗剂Zibotentan (ZD4054)是一种有效且特异性的ETA受体(内皮素A受体)拮抗剂(IC50 = 21 nM),对ETB没有抑制活性。 了解更多 -
Ambrisentan (BSF 208075)
Catalog No. A11291 EndothelinA receptor 拮抗剂Ambrisentan (BSF 208075)充当内皮素受体拮抗剂,对A型内皮素受体(ETA)具有选择性。 了解更多 -
Avosentan (SPP301)
Catalog No. A11301 -
Sitaxsentan sodium (TBC-11251)
Catalog No. A11564 ETA receptor 拮抗剂Sitaxsentan sodium (TBC-11251)是一种选择性内皮素受体A拮抗剂,IC50和Ki分别为1.4 nM和0.43 nM。 了解更多 -
Atrasentan
Catalog No. A13779 ETA 拮抗剂Atrasentan是一种实验药物,正在研究中,用于治疗各种类型的癌症,包括非小细胞肺癌。它是对A型亚型(ETA)有选择性的内皮素受体拮抗剂,对ETA的IC50为0.0551 nM。 了解更多 -
Atrasentan HCl
Catalog No. A15007 Endothelin 拮抗剂 receptorAtrasentan hydrochloride是一种开发用于治疗前列腺癌的内皮素拮抗剂受体(IC50 = 0.0551 nM,ETA)。 了解更多 -
BQ-123
Catalog No. A15912 -
Bosentan Hydrate
Catalog No. A14944 -
Aprocitentan
Catalog No. A21999 dual ETA/ETB antagonistAprocitentan (ACT-132577) is the major and pharmacologically active metabolite of Macitentan. Aprocitentan is dual ETA/ETB antagonist with IC50s of 3.4 nM and 987 nM, and pA2 valus of 6.7 and 5.5, respectively. 了解更多 -
Macitentan (n-butyl analogue)
Catalog No. A21845 endothelin ETA and ETB receptor antagonistMacitentan n-butyl analogue is a n-butyl analogue of Macitentan. Macitentan is an orally active, non-peptide dual endothelin ETA and ETB receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). 了解更多 -
Darusentan
Catalog No. A21280 endothelin A (ETA) receptor antagonistDarusentan is a selective endothelin A (ETA) receptor antagonist. 了解更多 -
Tezosentan
Catalog No. A21118 endothelin (ET) receptor antagonistTezosentan (RO 610612) is an endothelin (ET) receptor antagonist, with pA2s of 9.5, 7.7 for ETA and ETB receptors, respectively. 了解更多 -
Sparsentan
Catalog No. A20879 angiotensin II and endothelin A receptor antagonistSparsentan (RE-021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively. 了解更多 -
Macitentan
Catalog No. A11492 Endothelin receptor 拮抗剂Macitentan是一种口服活性非肽双重ETA/ETB(内皮素) receptor双重拮抗剂,IC50为0.5 nM/391 nM。用于治疗特发性肺纤维化(IPF)和肺动脉高压(PAH)。 了解更多